These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11294971)

  • 1. Applications of mechanistic data in risk assessment: the past, present, and future.
    Haber LT; Maier A; Zhao Q; Dollarhide JS; Savage RE; Dourson ML
    Toxicol Sci; 2001 May; 61(1):32-9. PubMed ID: 11294971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses.
    Schlosser PM; Lilly PD; Conolly RB; Janszen DB; Kimbell JS
    Risk Anal; 2003 Jun; 23(3):473-87. PubMed ID: 12836840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
    Kitchin KT; Conolly R
    Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving cancer dose-response characterization by using physiologically based pharmacokinetic modeling: an analysis of pooled data for acrylonitrile-induced brain tumors to assess cancer potency in the rat.
    Kirman CR; Hays SM; Kedderis GL; Gargas ML; Strother DE
    Risk Anal; 2000 Feb; 20(1):135-51. PubMed ID: 10795346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action and tissue dosimetry in current and future risk assessments.
    Andersen ME; Dennison JE
    Sci Total Environ; 2001 Jul; 274(1-3):3-14. PubMed ID: 11453304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches for applications of physiologically based pharmacokinetic models in risk assessment.
    Thompson CM; Sonawane B; Barton HA; DeWoskin RS; Lipscomb JC; Schlosser P; Chiu WA; Krishnan K
    J Toxicol Environ Health B Crit Rev; 2008 Aug; 11(7):519-47. PubMed ID: 18584453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
    Kirman CR; Sweeney LM; Corley R; Gargas ML
    Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to cancer assessment in EPA's Integrated Risk Information System.
    Gehlhaus MW; Gift JS; Hogan KA; Kopylev L; Schlosser PM; Kadry AR
    Toxicol Appl Pharmacol; 2011 Jul; 254(2):170-80. PubMed ID: 21034767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
    Bogen KT
    Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach for integrating toxicogenomic data in risk assessment: the dibutyl phthalate case study.
    Euling SY; Thompson CM; Chiu WA; Benson R
    Toxicol Appl Pharmacol; 2013 Sep; 271(3):324-35. PubMed ID: 23537663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone.
    Gentry PR; Covington TR; Clewell HJ; Anderson ME
    J Toxicol Environ Health A; 2003 Dec; 66(23):2209-25. PubMed ID: 14612334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What role for biologically based dose-response models in estimating low-dose risk?
    Crump KS; Chen C; Chiu WA; Louis TA; Portier CJ; Subramaniam RP; White PD
    Environ Health Perspect; 2010 May; 118(5):585-8. PubMed ID: 20056564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mechanistic information in risk assessment for toxic chemicals.
    Becking GC
    Toxicol Lett; 1995 May; 77(1-3):15-24. PubMed ID: 7618129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop.
    Bogdanffy MS; Daston G; Faustman EM; Kimmel CA; Kimmel GL; Seed J; Vu V
    Toxicol Sci; 2001 May; 61(1):18-31. PubMed ID: 11294970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
    Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
    Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compounds.
    Andersen ME; Meek ME; Boorman GA; Brusick DJ; Cohen SM; Dragan YP; Frederick CB; Goodman JI; Hard GC; O'Flaherty EJ; Robinson DE
    Toxicol Sci; 2000 Feb; 53(2):159-72. PubMed ID: 10696764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: an example with acrylic acid.
    Andersen M; Sarangapani R; Gentry R; Clewell H; Covington T; Frederick CB
    Toxicol Sci; 2000 Oct; 57(2):312-25. PubMed ID: 11006361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of biologically based dose-response modeling for developmental toxicity: a workshop report.
    Lau C; Andersen ME; Crawford-Brown DJ; Kavlock RJ; Kimmel CA; Knudsen TB; Muneoka K; Rogers JM; Setzer RW; Smith G; Tyl R
    Regul Toxicol Pharmacol; 2000 Apr; 31(2 Pt 1):190-9. PubMed ID: 10854125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.